Trial Profile
A Randomised, Double-Blind, Placebo Controlled, Parallel Group , Flexible Dose Study to Evaluate the Efficacy and Safety of Paxil Tablets in Children and Adolescents With Major Depressive Disorder Post-Marketing Clinical Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 10 Sep 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 13 May 2011 Actual end date Feb 2011 added as reported by ClinicalTrials.gov
- 13 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov